• Explore /
  • Poster
  • / Genomic, clinical characteristics, and treatment outcomes of patients with metastatic castration-sensitive prostate cancer with SPOP mutations: Analysis from the Kaiser Permanente Northern California Healthcare System.

Genomic, clinical characteristics, and treatment outcomes of patients with metastatic castration-sensitive prostate cancer with SPOP mutations: Analysis from the Kaiser Permanente Northern California Healthcare System.

Abstract Poster

Authors

Sachdev Thomas, I

Sachdev P. Thomas

The Permanente Medical Group, Department of Hematology Oncology, Vallejo, CA

Sachdev P. Thomas , Amit Arora , Hui X. Huang , Chen Jiang , Elaine Chung , Jennifer Marie Suga , Tilak Kumar Sundaresan , Thach-Giao Truong , Minggui Pan , Andrea Harzstark

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Prostate Cancer

Track

Prostate Cancer - Advanced,Prostate Cancer - Localized

Sub Track

Translational Research, Tumor Biology, Biomarkers, and Pathology

Citation

J Clin Oncol 41, 2023 (suppl 6; abstr 261)

DOI

10.1200/JCO.2023.41.6_suppl.261

Abstract #

261

Poster Bd #

J18

Abstract Disclosures

Similar Posters

Poster

2021 Genitourinary Cancers Symposium

<em>SPOP</em> mutations in prostate cancer: Clinical and genomic features.

SPOP mutations in prostate cancer: Clinical and genomic features.

First Author: Mari Nakazawa

First Author: Charles J. Ryan

First Author: Hirotsugu Uemura

First Author: Xiao X. Wei